Eris Lifesciences Ltd shared an investor presentation on May 19, 2025, highlighting a 28% increase in Q4 FY25 revenue to Rs. 705 crore and a 70% growth in EBITDA to Rs. 252 crore.
AI Assistant
ERIS Lifesciences Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.